WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Backs Independent Pricing for Innovative Drugs in Landmark State Council... China has unveiled a sweeping new blueprint, to overhaul how drug prices are set, with policymakers endorsing market-led pricing, backing independent pricing for innova...
(4/9/2026)

China Backs Independent Pricing for Innovative... (4/9/2026)

China's Innovative Drug Out-Licensing Surge To... (4/9/2026)

Global Drugmakers Brace for Another Tough Chin... (4/8/2026)

Pharma Bets Big on Chinese Drugmakers (The Wir... (4/7/2026)

China NMPA Clears 17 Novel Drugs in First Quar... (4/7/2026)

China's $13B Pharma Boom Drives Growth But Fac... (4/3/2026)

Biotech VCs Move Upstream in China as Competit... (4/1/2026)

IQVIA Report Highlights Rising Use and Intensi... (3/25/2026)

Global Pharma Ramps Up China Investment as 15t... (3/24/2026)

US Reshoring Push Clouds Long-Term Outlook for... (3/17/2026)

China to Grant Market and Data Exclusivity for... (3/17/2026)

China Private Biotech Financing Slows in Febru... (3/13/2026)

CDE Releases New Clinical Evaluation Gui... (4/9/2026) CDE Issues New Clinical Evaluation Guide... (4/9/2026) Syneron Emerges as a Macrocycle Powerhou... (4/9/2026) Luye Advances Next-Gen Schizophrenia Can... (4/9/2026) Over Half of China-Listed Drugmakers Gro... (4/9/2026) Gan & Lee Out-Licenses Bi-Weekly GLP-1 C... (4/9/2026) GSK Wins China Approval for Exdensur in ... (4/9/2026) NMPA Clears BioGenesis's Recombinant Hum... (4/9/2026) Everest Medicines to Acquire Hasten's As... (4/9/2026) NMPA Adopts ICH M14 Guideline, Expanding... (4/8/2026) NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5) (4/8/2026) Merck and Zhifei Shift to Demand-Based C... (4/8/2026) Aidea Wins China IND Clearance for Long-... (4/7/2026) Bayer Deepens China Innovation Push as P... (4/7/2026) Kelun-Biotech and HBM's Atopic Dermatiti... (4/7/2026) Chengdu NRT Closes CNY 1B Series E to Ac... (4/7/2026) Henlius Wins China IND Approval for HLX3... (4/7/2026) Adagene, Incyte Launch Clinical Collabor... (4/7/2026)

China Pharma Market Set for Structural Shift as Innovat... China Pharmaceutical Market Projected to Reach US$573B ... China's Vaccine Exports Jump More Than 50% in 2025 as O... China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ...

Everest Medicines to Acquire Hasten's Asia-Pacific Plat... Gan & Lee Out-Licenses Bi-Weekly GLP-1 Candidate Bofang... Over Half of China-Listed Drugmakers Grow 2025 Profit a... Syneron Emerges as a Macrocycle Powerhouse as Funding a... Merck and Zhifei Shift to Demand-Based China Vaccine Su...

CDE Issues New Clinical Evaluation Guideline for Drug M... CDE Releases New Clinical Evaluation Guideline for IND ... NMPA Adopts ICH Q8, Q9 and Q10 Q&A (R5) NMPA Adopts ICH M14 Guideline, Expanding China's Regula... CDE Revises Drug R&D and Technical Review Communication...

China Tightens Health Insurance Fund Oversight With New... China Issues New Policy to Strengthen Primary Healthcar... New NHSA Report Highlights Expanding Coverage and Refor... NHSA: China Medical Insurance Revenue Growth Outpaces S... China's Average Life Expectancy Hits 79.25 Years in 202...

Bayer Secures Nearly Five-Year China Patent Extension f... U.S. ITC to Probe China's Trade Status and Biotech Prac... China Schedules Antitrust Hearing in Abuse‑of‑Dominan... Pentagon Reverses Decision After Briefly Listing WuXi A... China Indicts AstraZeneca and Former China Head Leon Wa...

India Still Relies Heavily on China for Essential Pharm... Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac...

NMPA Clears BioGenesis's Recombinant Human Hyaluronidas... GSK Wins China Approval for Exdensur in Chronic Rhinosi... Luye Advances Next-Gen Schizophrenia Candidate LY03020 ... Henlius Wins China IND Approval for HLX319, Advancing S... Abbisko Advances ABSK061 Into US Clinical Development f...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...